[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356173-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356173-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","building-bridges-to-immunotherapy-a-knowledge-mapping-analysis-of-cervical-cancer-organoid-research","Building bridges to immunotherapy - a knowledge-mapping analysis of cervical cancer organoid research","","Bibliometric study maps the knowledge structure of patient-derived organoid (PDO) research in cervical cancer immunotherapy. Using 130 publications from Web of Science, PubMed, and Scopus (1992–2025) analyzed with VOSviewer and CiteSpace, the work identifies a three-stage evolution from HPV virology and culture foundations to organoid methodology establishment and the current translational phase. Citation bursts, emerging keywords such as “drug screening” and “immunotherapy,” and geographical leadership are characterized. Findings emphasize organoids as a bridge linking basic virology with clinical immuno-oncology, while highlighting standardization and immune-competent co-culture needs for translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/building-bridges-to-immunotherapy-a-knowledge-mapping-analysis-of-cervical-cancer-organoid-research/356173/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/building-bridges-to-immunotherapy-a-knowledge-mapping-analysis-of-cervical-cancer-organoid-research/356173.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What research method is used to analyze cervical cancer organoid immunotherapy?","Question",{"text":63,"@type":64},"The document uses bibliometric analysis based on 130 publications from Web of Science, PubMed, and Scopus, analyzed with VOSviewer and CiteSpace.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What time span and publication sources are included?",{"text":68,"@type":64},"It covers publications from 1992 to 2025 and draws records from Web of Science, PubMed, and Scopus.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the study position PDOs compared with traditional models like 2D culture or PDX?",{"text":72,"@type":64},"The study argues that PDOs better preserve the native human tumor microenvironment, while 2D culture cannot represent TME complexity and PDX models often lack intact human immunity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356173,1790182578,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":26,"preview_urls":147},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Systematic Review PUBLISHED 24 August 2026  \nDOI 10.3389/fimmu.2026.1788725  \nOPEN ACCESS  \nEDITED BY  \nRaja Choudhury,  \nKarolinska Institutet (KI), Sweden  \nREVIEWED BY  \nElena Niculet,  \nDunarea de Jos University, Romania Ayush Madan,  \nPeople’s University School of Research & Technology, India  \n*CORRESPONDENCE  \nXin Zhao  \n [zdsfyzx@zzu.edu.cn](zdsfyzx@zzu.edu.cn)  \nRECEIVED 15 January 2026  \nREVISED 03 August 2026  \nACCEPTED 05 August 2026  \nPUBLISHED 24 August 2026  \nCITATION  \nTian Y, Chang H, Liu J, Ding W, Jin J, Qin C, Zhao S and Zhao X (2026)  \nBuilding bridges to immunotherapy: a knowledge-mapping analysis of cervical cancer organoid research.  \nFront. Immunol. 17:1788725 .  \ndoi: 10.3389/fimmu.2026.1788725  \nCOPYRIGHT  \n© 2026 Tian, Chang, Liu, Ding, Jin, Qin, Zhao and Zhao. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nBuilding bridges to immunotherapy: a knowledgemapping analysis of cervical cancer organoid research  \nYuanyuan Tian 1,2, Hui Chang 1, Jinjin Liu 1, Wenjun Ding 1, Jian Jin 1, Chi Qin 1, Shuoshi Zhao 1 and Xin Zhao 1,2*  \n1 Department of Clinical Research and Translational Medicine, the Third Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, 2Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, China  \nCervical cancer, a human papillomavirus (HPV) -driven malignancy with inherent viral antigenicity, serves as a key model in immuno-oncology. Yet, the variable efﬁcacy of immune checkpoint inhibitors highlights a critical gap: the lack of preclinical models that accurately mirror the patient-speciﬁc tumor microenvironment (TME) . Patient-derived organoids (PDOs) offer a transformative solution, preserving autologous tumor and immune components for personalized therapeutic testing. This study provides the ﬁrst bibliometric analysis of this evolving ﬁeld, mapping its knowledge structure from model development to immunooncological application. By analyzing 130 publications (1992-2025) from Web of Science, PubMed, and Scopus using VOSviewer and CiteSpace, we delineate a clear, three-stage evolution: from foundational HPV virology and culture techniques, through pivotal organoid methodology establishment (e. g., Burk RD, 2017), to the current translational phase. This progression is marked by citation bursts in TME modeling (e.g., Lohmussaar K, 2021) and the emergence of keywords like “drug screening” and “immunotherapy”. Research is dominated by the U.S., China, and European nations, published within an interdisciplinary core of oncology, immunology, and virology journals. Our analysis highlights the role of organoids as a crucial bridge linking basic virology to clinical immunooncology. However, standardization hurdles and suboptimal establishment rates for certain subtypes impede clinical translation. To realize the full potential of PDOs, future work must prioritize standardized immune-competent coculture systems, integrate AI for high-content data analysis, and promote equitable global collaborations. Our analysis suggests the role of organoids as a crucial bridge linking basic virology to clinical immuno-oncology, highlighting that current advancements in tumor microenvironment modeling are establishing the necessary foundation for future immunotherapeutic applications.  \nKEYWORDS  \n3D culture, bibliometric analysis, cervical cancer organoids, human papillomavirus, precision medicine  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nCervical Cancer is the fourth ","cbCaieNmjly4eWbQ","https://ap.wps.com/l/cbCaieNmjly4eWbQ","pdf",19444577,15,"English","# Introduction\n## Global burden of cervical cancer and treatment challenges\n## Modeling limitations of 2D culture and PDX\n## PDOs as a solution for patient-specific TME preservation","[{\"question\":\"What research method is used to analyze cervical cancer organoid immunotherapy?\",\"answer\":\"The document uses bibliometric analysis based on 130 publications from Web of Science, PubMed, and Scopus, analyzed with VOSviewer and CiteSpace.\"},{\"question\":\"What time span and publication sources are included?\",\"answer\":\"It covers publications from 1992 to 2025 and draws records from Web of Science, PubMed, and Scopus.\"},{\"question\":\"How does the study position PDOs compared with traditional models like 2D culture or PDX?\",\"answer\":\"The study argues that PDOs better preserve the native human tumor microenvironment, while 2D culture cannot represent TME complexity and PDX models often lack intact human immunity.\"}]","Building bridges to immunotherapy - a knowledge-mapping analysis of cervical cancer organoid research | PDF",1790123863,38,[148,152],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/ad3350d8e9fa232764ecd42bad5caf8d.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/870473d577704c618ff29dde3bf1ae1b.webp",982,1388]